Fresh Data, Fast Impact: Myeloma Updates

Held just weeks after ASCO and EHA, this interactive 45-minute roundtable will highlight the timeliest and most practice-relevant updates in multiple myeloma. Moderated by program co-chair Dr. Joseph Mikhael and led by a panel of expert myeloma faculty, the discussion will focus on key data, emerging trends, and clinical implications. Audience engagement will drive a dynamic exchange on how new findings may influence real-world decision-making.